| P2093 | author name string | Frieder Keller | |
| | David Czock | |
| | Bertram Hartmann | |
| | Caecilia Holch | |
| | Florian Thalhammer | |
| | Sebastian Maus | |
| P2860 | cites work | A new equation to estimate glomerular filtration rate | Q24651973 |
| | Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy". | Q35099758 |
| | Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration | Q35826283 |
| | Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. | Q36739927 |
| | Structured data entry for reliable acquisition of pharmacokinetic data | Q36836339 |
| | Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development | Q36949430 |
| | Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy | Q37008814 |
| | Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America | Q37461442 |
| | Nomograms for drug use in renal disease | Q40307286 |
| | Drug dosage in renal disease | Q40640491 |
| | Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? | Q41604148 |
| | Single or multiple daily doses of aminoglycosides: a meta-analysis | Q42145555 |
| | Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure | Q43815756 |
| | Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis | Q44094982 |
| | Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function | Q46385555 |
| | Assessment of vancomycin use in chronic haemodialysis patients: room for improvement. | Q46530255 |
| | Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients. | Q46537437 |
| | A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. | Q50509590 |
| | Therapeutic aminoglycoside monitoring in renal failure patients. | Q50573890 |
| | Standardized structure and modular design of a pharmacokinetic database. | Q52244361 |
| | Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH) | Q58880088 |
| | A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels | Q72229130 |
| | Dose individualization in PharmDIS-e+ | Q75219834 |
| | Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis | Q80797205 |
| | Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients | Q83204519 |
| | Pharmacokinetics and pharmacodynamics of antimicrobial drugs | Q83771226 |
| | Structured Data Entry for Reliable Acquisition of Pharmacokinetic Data | Q114645131 |
| P433 | issue | 15-16 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | questionnaire | Q747810 |
| | drug administration schedule | Q73398352 |
| P304 | page(s) | 479-485 | |
| P577 | publication date | 2010-08-04 | |
| P1433 | published in | Vienna Clinical Weekly | Q15759796 |
| P1476 | title | Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function | |
| P478 | volume | 122 | |